Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consequences of Amyloid-β Deficiency for the Liver.
Buniatian GH, Schwinghammer U, Tremmel R, Cynis H, Weiss TS, Weiskirchen R, Lauschke VM, Youhanna S, Ramos I, Valcarcel M, Seferyan T, Rahfeld JU, Rieckmann V, Klein K, Buadze M, Weber V, Kolak V, Gebhardt R, Friedman SL, Müller UC, Schwab M, Danielyan L. Buniatian GH, et al. Among authors: ramos i. Adv Sci (Weinh). 2024 May;11(18):e2307734. doi: 10.1002/advs.202307734. Epub 2024 Mar 2. Adv Sci (Weinh). 2024. PMID: 38430535 Free PMC article.
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents.
Antonijevic M, Charou D, Davis A, Curel T, Valcarcel M, Ramos I, Villacé P, Claeysen S, Dallemagne P, Gravanis A, Charalampopoulos I, Rochais C. Antonijevic M, et al. Among authors: ramos i. Molecules. 2024 Jan 19;29(2):515. doi: 10.3390/molecules29020515. Molecules. 2024. PMID: 38276593 Free PMC article.
Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity.
Rogdakis T, Charou D, Latorrata A, Papadimitriou E, Tsengenes A, Athanasiou C, Papadopoulou M, Chalikiopoulou C, Katsila T, Ramos I, Prousis KC, Wade RC, Sidiropoulou K, Calogeropoulou T, Gravanis A, Charalampopoulos I. Rogdakis T, et al. Among authors: ramos i. Biomedicines. 2022 Mar 6;10(3):614. doi: 10.3390/biomedicines10030614. Biomedicines. 2022. PMID: 35327415 Free PMC article.
New Potent Inhibitor of Transforming Growth Factor-Beta (TGFβ) Signaling that is Efficacious against Microsatellite Stable Colorectal Cancer Metastasis in Combination with Immune Checkpoint Therapy in Mice.
Tauriello DVF, Sancho E, Byrom D, Sanchez-Zarzalejo C, Salvany M, Henriques A, Palomo-Ponce S, Sevillano M, Hernando-Momblona X, Matarin JA, Ramos I, Ruano I, Prats N, Batlle E, Riera A. Tauriello DVF, et al. Among authors: ramos i. ACS Pharmacol Transl Sci. 2024 Oct 1;8(1):97-112. doi: 10.1021/acsptsci.4c00374. eCollection 2025 Jan 10. ACS Pharmacol Transl Sci. 2024. PMID: 39816803
Nursing students and the internet: a reflection of digital ethics.
Brandão ACB, Ramos IB, Oliveira ACCG, Duarte SDCM, Tavares JMAB, Broca PV. Brandão ACB, et al. Among authors: ramos ib. Rev Bras Enferm. 2025 Jan 10;77Suppl 4(Suppl 4):e20230459. doi: 10.1590/0034-7167-2023-0459. eCollection 2025. Rev Bras Enferm. 2025. PMID: 39813494 Free PMC article.
Starvation Metabolism Adaptations in Tick Embryonic Cells BME26.
Nogueira CL, Arcanjo AF, Lima ME, Moraes B, da Silva RM, Gondim KC, Konnai S, Ramos I, Santos S, Filardy AD, Pinto KG, Vaz Junior IDS, Logullo C. Nogueira CL, et al. Among authors: ramos i. Int J Mol Sci. 2024 Dec 26;26(1):87. doi: 10.3390/ijms26010087. Int J Mol Sci. 2024. PMID: 39795947 Free PMC article.
680 results